Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation
Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation
dc.contributor.author | Antunes, Heilton S | |
dc.contributor.author | Schluckebier, Luciene Fontes | |
dc.contributor.author | Herchenhorn, Daniel | |
dc.contributor.author | Small, Isabele A. | |
dc.contributor.author | Araújo, Carlos M.M. | |
dc.contributor.author | Viégas, Celia Maria Pais | |
dc.contributor.author | Rampini, Mariana P. | |
dc.contributor.author | Ferreira, Elza M.S. | |
dc.contributor.author | Dias, Fernando L. | |
dc.contributor.author | Teich, Vanessa | |
dc.contributor.author | Teich, Nelson | |
dc.contributor.author | Ferreira, Carlos G. | |
dc.date.accessioned | 2022-08-16T12:54:59Z | |
dc.date.available | 2022-08-16T12:54:59Z | |
dc.date.issued | 2016 | |
dc.description.abstract | Background: Oral mucositis is a major event increasing treatment costs of head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiation (CRT). This study was designed to estimate the cost-effectiveness of low-level laser therapy (LLLT) to prevent oral mucositis in HNSCC patients receiving CRT. Methods: From June 2007 to December 2010, 94 patients with HNSCC of nasopharynx, oropharynx, and hypopharynx entered a prospective, randomized, double blind, placebo-controlled, phase III trial. CRT consisted of conventional radiotherapy (RT: 70.2 Gy, 1.8 Gy/d, 5 times/wk) + concurrent cisplatin (100 mg/m2 ) every 3 weeks. An InGaAlP (660 nm–100 mW–4 J/cm2 ) laser diode was used for LLLT. Results: From the perspective of Brazil’s public health care system (SUS), total costs were higher in Placebo Group (PG) than Laser Group (LG) for opioid use (LG = US$ 9.08, PG = US$ 44.28), gastrostomy feeding (LG = US$ 50.50, PG = US$ 129.86), and hospitalization (PG = US$ 77.03). In LG, the cost was higher for laser therapy only (US$ 1880.57). The total incremental cost associated with the use of LLLT was US$ 1689.00 per patient. The incremental cost-effectiveness ratio (ICER) was US$ 4961.37 per grade 3–4 OM case prevented compared to no treatment. Conclusions: Our results indicate that morbidity was lower in the Laser Group and that LLLT was more cost-effective than placebo up to a threshold of at least US$ 5000 per mucositis case prevented. Clinical trial information: NCT01439724. | |
dc.identifier.citation | Antunes,HS, Schluckebier LF, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP et al. Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation. Oral Oncol. 2016;52:85-90. Doi: 10.1016/j.oraloncology.2015.10.022. | |
dc.identifier.other | DOI: 10.1016/j.oraloncology.2015.10.022 | |
dc.identifier.uri | https://dspace.inc.saude.gov.br/handle/123456789/90 | |
dc.language.iso | en | |
dc.publisher | Oral Oncology | |
dc.subject | Cost-effectiveness | en |
dc.subject | Low-level laser therapy | en |
dc.subject | Oral mucositis | en |
dc.subject | Head and neck cancer | en |
dc.subject | Radiotherapy | en |
dc.subject | Chemotherapy | en |
dc.subject | Quality of life | en |
dc.subject.mesh | Treatment Outcome | en |
dc.subject.mesh | Prospective Studies | en |
dc.subject.mesh | Mucositis / prevention & control | en |
dc.subject.mesh | Mucositis / economics | en |
dc.subject.mesh | Middle Aged | en |
dc.subject.mesh | Male | en |
dc.subject.mesh | Low-Level Light Therapy / economics | en |
dc.subject.mesh | Humans | en |
dc.subject.mesh | Head and Neck Neoplasms / therapy | en |
dc.subject.mesh | Head and Neck Neoplasms / economics | en |
dc.subject.mesh | Female | en |
dc.subject.mesh | Double-Blind Method | en |
dc.subject.mesh | Cost-Benefit Analysis | en |
dc.subject.mesh | Chemoradiotherapy / economics | en |
dc.subject.mesh | Chemoradiotherapy / adverse effects | en |
dc.subject.mesh | Carcinoma, Squamous Cell / therapy | en |
dc.subject.mesh | Carcinoma, Squamous Cell / economics | en |
dc.subject.mesh | Brazil | en |
dc.subject.mesh | Aged | en |
dc.title | Cost-effectiveness of low-level laser therapy (LLLT) in head and neck cancer patients receiving concurrent chemoradiation | |
dc.type | Article |